Drug recall
NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL
FDA recall event 72999 · Class III · Teva Pharmaceuticals USA
Key facts
| Event ID | 72999 |
|---|---|
| Recall numbers | D-0773-2016 |
| Recalling firm | Teva Pharmaceuticals USA |
| Product type | Drugs |
| Products | NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles. |
| Initiation date | Nov 19, 2015 |
| Report date | Mar 23, 2016 |
| Termination date | Nov 15, 2016 |
| City | North Wales |
| State | PA |
| Country | United States |
| FEI number | 3003092769 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: